A new wearable monitor to track heart and lung health
This study tests a device called UltraTrac that checks your heart and lung health without needles or invasive procedures. It may help doctors better monitor conditions like heart failure or asthma in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 2 months and 95 years old.
- You may have heart or lung conditions, but they must be stable (no ER visit or hospital stay in the last 30 days).
- If you are a woman who can become pregnant, you must use birth control and not be pregnant or nursing.
- You must not have skin irritation, rashes, or allergies to adhesives or gels on the areas where the device goes.
- You must be able to understand and follow the study rules, and provide consent (or a guardian must).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new non-invasive device called UltraTrac that measures how well the heart pumps blood in people with congenital heart disease. It will be used during standard heart procedures or intensive care stays to see if it works as well as current methods.
This study tests an investigational medical device (the UltraTrac) worn on the skin while children undergo a routine heart catheterization. The device aims to improve monitoring during the procedure and may help guide care more safely.
This trial tests a new, soft, wearable monitor that tracks your heart and body signs without wires or sticky pads. It aims to see if this device can help doctors diagnose and treat heart disease more comfortably.
This study tests an AI-powered wearable patch (the COR ECG) to see if it can better track heart and lung health. It may help doctors find problems earlier without needing bulky equipment.
This study is testing a new monitoring system that keeps track of your vital signs (like heart rate and breathing) while you are in the hospital. The goal is to see if the system works well and is easy to use, which could make monitoring more comfortable and continuous for patients like you.
This trial tests whether checking in remotely (telemonitoring) helps doctors adjust heart failure medications more effectively. It is for people newly diagnosed with heart failure who have reduced pumping strength and signs of fluid buildup.
Hear when a new Hemodynamic Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.